Global Personalized Cancer Treatment Market Insights, Forecast to 2031

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Personalized Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
  • 1.2.2 Personalized Medical Diagnosis
  • 1.2.3 Personalized Medical Treatment
• 1.3 Market by Application
  • 1.3.1 Global Personalized Cancer Treatment Market Share by Application: 2020 VS 2024 VS 2031
  • 1.3.2 Hospital
  • 1.3.3 Clinic
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Personalized Cancer Treatment Market Perspective (2020-2031)
• 2.2 Global Personalized Cancer Treatment Growth Trends by Region
  • 2.2.1 Global Personalized Cancer Treatment Market Size by Region: 2020 VS 2024 VS 2031
  • 2.2.2 Personalized Cancer Treatment Market Size by Region (2020-2031)
• 2.3 Personalized Cancer Treatment Market Dynamics
  • 2.3.1 Personalized Cancer Treatment Industry Trends
  • 2.3.2 Personalized Cancer Treatment Market Drivers
  • 2.3.3 Personalized Cancer Treatment Market Challenges
  • 2.3.4 Personalized Cancer Treatment Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Revenue Personalized Cancer Treatment by Players
  • 3.1.1 Global Personalized Cancer Treatment Revenue by Players (2020-2025)
  • 3.1.2 Global Personalized Cancer Treatment Revenue Market Share by Players (2020-2025)
• 3.2 Global Personalized Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Key Players of Personalized Cancer Treatment, Ranking by Revenue, 2023 VS 2024 VS 2025
• 3.4 Global Market Concentration Ratio
  • 3.4.1 Global Personalized Cancer Treatment Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Personalized Cancer Treatment Revenue in 2024
• 3.5 Global Key Players of Personalized Cancer Treatment Head office and Area Served
• 3.6 Global Key Players of Personalized Cancer Treatment, Product and Application
• 3.7 Global Key Players of Personalized Cancer Treatment, Date of Enter into This Industry
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type

• 4.1 Global Personalized Cancer Treatment Historic Market Size by Type (2020-2025)
• 4.2 Global Personalized Cancer Treatment Forecasted Market Size by Type (2026-2031)

5 Breakdown Data by Application

• 5.1 Global Personalized Cancer Treatment Historic Market Size by Application (2020-2025)
• 5.2 Global Personalized Cancer Treatment Forecasted Market Size by Application (2026-2031)

6 North America

• 6.1 North America Personalized Cancer Treatment Market Size (2020-2031)
• 6.2 North America Market Size by Type
  • 6.2.1 North America Personalized Cancer Treatment Market Size by Type (2020-2031)
  • 6.2.2 North America Personalized Cancer Treatment Market Share by Type (2020-2031)
• 6.3 North America Market Size by Application
  • 6.3.1 North America Personalized Cancer Treatment Market Size by Application (2020-2031)
  • 6.3.2 North America Personalized Cancer Treatment Market Share by Application (2020-2031)
• 6.4 North America Market Size by Country
  • 6.4.1 North America Personalized Cancer Treatment Market Size by Country: 2020 VS 2024 VS 2031
  • 6.4.2 North America Personalized Cancer Treatment Market Size by Country (2020-2031)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Personalized Cancer Treatment Market Size (2020-2031)
• 7.2 Europe Market Size by Type
  • 7.2.1 Europe Personalized Cancer Treatment Market Size by Type (2020-2031)
  • 7.2.2 Europe Personalized Cancer Treatment Market Share by Type (2020-2031)
• 7.3 Europe Market Size by Application
  • 7.3.1 Europe Personalized Cancer Treatment Market Size by Application (2020-2031)
  • 7.3.2 Europe Personalized Cancer Treatment Market Share by Application (2020-2031)
• 7.4 Europe Market Size by Country
  • 7.4.1 Europe Personalized Cancer Treatment Market Size by Country: 2020 VS 2024 VS 2031
  • 7.4.2 Europe Personalized Cancer Treatment Market Size by Country (2020-2025)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 China

• 8.1 China Personalized Cancer Treatment Market Size (2020-2031)
• 8.2 China Market Size by Type
  • 8.2.1 China Personalized Cancer Treatment Market Size by Type (2020-2031)
  • 8.2.2 China Personalized Cancer Treatment Market Share by Type (2020-2031)
• 8.3 China Market Size by Application
  • 8.3.1 China Personalized Cancer Treatment Market Size by Application (2020-2031)
  • 8.3.2 China Personalized Cancer Treatment Market Share by Application (2020-2031)

9 Asia (excluding China)

• 9.1 Asia Personalized Cancer Treatment Market Size (2020-2031)
• 9.2 Asia Market Size by Type
  • 9.2.1 Asia Personalized Cancer Treatment Market Size by Type (2020-2031)
  • 9.2.2 Asia Personalized Cancer Treatment Market Share by Type (2020-2031)
• 9.3 Asia Market Size by Application
  • 9.3.1 Asia Personalized Cancer Treatment Market Size by Application (2020-2031)
  • 9.3.2 Asia Personalized Cancer Treatment Market Share by Application (2020-2031)
• 9.4 Asia Market Size by Region
  • 9.4.1 Asia Personalized Cancer Treatment Market Size by Region: 2020 VS 2024 VS 2031
  • 9.4.2 Asia Personalized Cancer Treatment Market Size by Region (2020-2031)
  • 9.4.3 Japan
  • 9.4.4 South Korea
  • 9.4.5 China Taiwan
  • 9.4.6 Southeast Asia
  • 9.4.7 India
  • 9.4.8 Australia

10 Middle East, Africa, and Latin America

• 10.1 Middle East, Africa, and Latin America Personalized Cancer Treatment Market Size (2020-2031)
• 10.2 Middle East, Africa, and Latin America Market Size by Type
  • 10.2.1 Middle East, Africa, and Latin America Personalized Cancer Treatment Market Size by Type (2020-2031)
  • 10.2.2 Middle East, Africa, and Latin America Personalized Cancer Treatment Market Share by Type (2020-2031)
• 10.3 Middle East, Africa, and Latin America Market Size by Application
  • 10.3.1 Middle East, Africa, and Latin America Personalized Cancer Treatment Market Size by Application (2020-2031)
  • 10.3.2 Middle East, Africa, and Latin America Market Share by Application (2020-2031)
• 10.4 Middle East, Africa, and Latin America Market Size by Country
  • 10.4.1 Middle East, Africa, and Latin America Personalized Cancer Treatment Market Size by Country: 2020 VS 2024 VS 2031
  • 10.4.2 Middle East, Africa, and Latin America Personalized Cancer Treatment Market Size by Country (2020-2031)
  • 10.4.3 Brazil
  • 10.4.4 Mexico
  • 10.4.5 Turkey
  • 10.4.6 Saudi Arabia
  • 10.4.7 Israel
  • 10.4.8 GCC Countries

11 Key Players Profiles

• 11.1 Cellworks
  • 11.1.1 Cellworks Company Details
  • 11.1.2 Cellworks Business Overview
  • 11.1.3 Cellworks Personalized Cancer Treatment Introduction
  • 11.1.4 Cellworks Revenue in Personalized Cancer Treatment Business (2020-2025)
  • 11.1.5 Cellworks Recent Development
• 11.2 Novartis
  • 11.2.1 Novartis Company Details
  • 11.2.2 Novartis Business Overview
  • 11.2.3 Novartis Personalized Cancer Treatment Introduction
  • 11.2.4 Novartis Revenue in Personalized Cancer Treatment Business (2020-2025)
  • 11.2.5 Novartis Recent Development
• 11.3 Gradalis, Inc
  • 11.3.1 Gradalis, Inc Company Details
  • 11.3.2 Gradalis, Inc Business Overview
  • 11.3.3 Gradalis, Inc Personalized Cancer Treatment Introduction
  • 11.3.4 Gradalis, Inc Revenue in Personalized Cancer Treatment Business (2020-2025)
  • 11.3.5 Gradalis, Inc Recent Development
• 11.4 TherapySelect
  • 11.4.1 TherapySelect Company Details
  • 11.4.2 TherapySelect Business Overview
  • 11.4.3 TherapySelect Personalized Cancer Treatment Introduction
  • 11.4.4 TherapySelect Revenue in Personalized Cancer Treatment Business (2020-2025)
  • 11.4.5 TherapySelect Recent Development
• 11.5 Personalis
  • 11.5.1 Personalis Company Details
  • 11.5.2 Personalis Business Overview
  • 11.5.3 Personalis Personalized Cancer Treatment Introduction
  • 11.5.4 Personalis Revenue in Personalized Cancer Treatment Business (2020-2025)
  • 11.5.5 Personalis Recent Development
• 11.6 RGCC International
  • 11.6.1 RGCC International Company Details
  • 11.6.2 RGCC International Business Overview
  • 11.6.3 RGCC International Personalized Cancer Treatment Introduction
  • 11.6.4 RGCC International Revenue in Personalized Cancer Treatment Business (2020-2025)
  • 11.6.5 RGCC International Recent Development
• 11.7 Genentech
  • 11.7.1 Genentech Company Details
  • 11.7.2 Genentech Business Overview
  • 11.7.3 Genentech Personalized Cancer Treatment Introduction
  • 11.7.4 Genentech Revenue in Personalized Cancer Treatment Business (2020-2025)
  • 11.7.5 Genentech Recent Development
• 11.8 BMS
  • 11.8.1 BMS Company Details
  • 11.8.2 BMS Business Overview
  • 11.8.3 BMS Personalized Cancer Treatment Introduction
  • 11.8.4 BMS Revenue in Personalized Cancer Treatment Business (2020-2025)
  • 11.8.5 BMS Recent Development
• 11.9 OHC - Oncology Hematology Care
  • 11.9.1 OHC - Oncology Hematology Care Company Details
  • 11.9.2 OHC - Oncology Hematology Care Business Overview
  • 11.9.3 OHC - Oncology Hematology Care Personalized Cancer Treatment Introduction
  • 11.9.4 OHC - Oncology Hematology Care Revenue in Personalized Cancer Treatment Business (2020-2025)
  • 11.9.5 OHC - Oncology Hematology Care Recent Development
• 11.10 CTOAM
  • 11.10.1 CTOAM Company Details
  • 11.10.2 CTOAM Business Overview
  • 11.10.3 CTOAM Personalized Cancer Treatment Introduction
  • 11.10.4 CTOAM Revenue in Personalized Cancer Treatment Business (2020-2025)
  • 11.10.5 CTOAM Recent Development
• 11.11 Aadi Bioscience
  • 11.11.1 Aadi Bioscience Company Details
  • 11.11.2 Aadi Bioscience Business Overview
  • 11.11.3 Aadi Bioscience Personalized Cancer Treatment Introduction
  • 11.11.4 Aadi Bioscience Revenue in Personalized Cancer Treatment Business (2020-2025)
  • 11.11.5 Aadi Bioscience Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details
• 13.3 Disclaimer

List of Tables

Table 1. Global Personalized Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Personalized Medical Diagnosis

Table 3. Key Players of Personalized Medical Treatment

Table 4. Global Personalized Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Personalized Cancer Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Market Size by Region (2020-2031) & (US$ Million)

Table 7. Global Personalized Cancer Treatment Market Share by Region (2020-2031)

Table 8. Market Trends

Table 9. Market Drivers

Table 10. Market Challenges

Table 11. Market Restraints

Table 12. Global Personalized Cancer Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 13. Global Personalized Cancer Treatment Market Share by Players (2020-2025)

Table 14. Global Top Personalized Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Treatment as of 2024)

Table 15. Global Personalized Cancer Treatment Industry Ranking 2023 VS 2024

Table 16. Global 5 Largest Players Market Share by Personalized Cancer Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 17. Global Key Players of Personalized Cancer Treatment, Headquarters and Area Served

Table 18. Global Key Players of Personalized Cancer Treatment, Product and Application

Table 19. Global Key Players of Personalized Cancer Treatment, Date of Enter into This Industry

Table 20. Mergers & Acquisitions, Expansion Plans

Table 21. Global Market Size by Type (2020-2025) & (US$ Million)

Table 22. Global Personalized Cancer Treatment Revenue Market Share by Type (2020-2025)

Table 23. Global Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 24. Global Personalized Cancer Treatment Revenue Market Share by Type (2026-2031)

Table 25. Global Market Size by Application (2020-2025) & (US$ Million)

Table 26. Global Personalized Cancer Treatment Revenue Market Share by Application (2020-2025)

Table 27. Global Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 28. Global Personalized Cancer Treatment Revenue Market Share by Application (2026-2031)

Table 29. North America Market Size by Type (2020-2031) & (US$ Million)

Table 30. North America Market Size by Application (2020-2031) & (US$ Million)

Table 31. North America Personalized Cancer Treatment Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Market Size by Country (2020-2031) & (US$ Million)

Table 33. Europe Market Size by Type (2020-2031) & (US$ Million)

Table 34. Europe Market Size by Application (2020-2031) & (US$ Million)

Table 35. Europe Personalized Cancer Treatment Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Market Size by Country (2020-2025) & (US$ Million)

Table 37. China Market Size by Type (2020-2031) & (US$ Million)

Table 38. China Market Size by Application (2020-2031) & (US$ Million)

Table 39. Asia Market Size by Type (2020-2031) & (US$ Million)

Table 40. Asia Market Size by Application (2020-2025) & (US$ Million)

Table 41. Asia Personalized Cancer Treatment Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031

Table 42. Asia Market Size by Region (2020-2031) & (US$ Million)

Table 43. Middle East, Africa, and Latin America Market Size by Type (2020-2031) & (US$ Million)

Table 44. Middle East, Africa, and Latin America Market Size by Application (2020-2031) & (US$ Million)

Table 45. Middle East, Africa, and Latin America Personalized Cancer Treatment Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East, Africa, and Latin America Market Size by Country (2020-2031) & (US$ Million)

Table 47. Cellworks Company Details

Table 48. Cellworks Business Overview

Table 49. Cellworks Personalized Cancer Treatment Product

Table 50. Cellworks Revenue (2020-2025) & (US$ Million)

Table 51. Cellworks Recent Development

Table 52. Novartis Company Details

Table 53. Novartis Business Overview

Table 54. Novartis Personalized Cancer Treatment Product

Table 55. Novartis Revenue (2020-2025) & (US$ Million)

Table 56. Novartis Recent Development

Table 57. Gradalis, Inc Company Details

Table 58. Gradalis, Inc Business Overview

Table 59. Gradalis, Inc Personalized Cancer Treatment Product

Table 60. Gradalis, Inc Revenue (2020-2025) & (US$ Million)

Table 61. Gradalis, Inc Recent Development

Table 62. TherapySelect Company Details

Table 63. TherapySelect Business Overview

Table 64. TherapySelect Personalized Cancer Treatment Product

Table 65. TherapySelect Revenue (2020-2025) & (US$ Million)

Table 66. TherapySelect Recent Development

Table 67. Personalis Company Details

Table 68. Personalis Business Overview

Table 69. Personalis Personalized Cancer Treatment Product

Table 70. Personalis Revenue (2020-2025) & (US$ Million)

Table 71. Personalis Recent Development

Table 72. RGCC International Company Details

Table 73. RGCC International Business Overview

Table 74. RGCC International Personalized Cancer Treatment Product

Table 75. RGCC International Revenue (2020-2025) & (US$ Million)

Table 76. RGCC International Recent Development

Table 77. Genentech Company Details

Table 78. Genentech Business Overview

Table 79. Genentech Personalized Cancer Treatment Product

Table 80. Genentech Revenue (2020-2025) & (US$ Million)

Table 81. Genentech Recent Development

Table 82. BMS Company Details

Table 83. BMS Business Overview

Table 84. BMS Personalized Cancer Treatment Product

Table 85. BMS Revenue (2020-2025) & (US$ Million)

Table 86. BMS Recent Development

Table 87. OHC - Oncology Hematology Care Company Details

Table 88. OHC - Oncology Hematology Care Business Overview

Table 89. OHC - Oncology Hematology Care Personalized Cancer Treatment Product

Table 90. OHC - Oncology Hematology Care Revenue (2020-2025) & (US$ Million)

Table 91. OHC - Oncology Hematology Care Recent Development

Table 92. CTOAM Company Details

Table 93. CTOAM Business Overview

Table 94. CTOAM Personalized Cancer Treatment Product

Table 95. CTOAM Revenue (2020-2025) & (US$ Million)

Table 96. CTOAM Recent Development

Table 97. Aadi Bioscience Company Details

Table 98. Aadi Bioscience Business Overview

Table 99. Aadi Bioscience Personalized Cancer Treatment Product

Table 100. Aadi Bioscience Revenue (2020-2025) & (US$ Million)

Table 101. Aadi Bioscience Recent Development

Table 102. Research Programs/Design for This Report

Table 103. Key Data Information from Secondary Sources

Table 104. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Personalized Cancer Treatment Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 2. Global Personalized Cancer Treatment Market Share by Type: 2024 VS 2031

Figure 3. Personalized Medical Diagnosis Features

Figure 4. Personalized Medical Treatment Features

Figure 5. Global Personalized Cancer Treatment Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Global Personalized Cancer Treatment Market Share by Application: 2024 VS 2031

Figure 7. Hospital Case Studies

Figure 8. Clinic Case Studies

Figure 9. Personalized Cancer Treatment Report Years Considered

Figure 10. Global Personalized Cancer Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 11. Global Personalized Cancer Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Personalized Cancer Treatment Market Share by Region: 2024 VS 2031

Figure 13. Global Personalized Cancer Treatment Market Share by Players in 2024

Figure 14. Global Top Personalized Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Treatment as of 2024)

Figure 15. The Top 10 and 5 Players Market Share by Personalized Cancer Treatment Revenue in 2024

Figure 16. North America Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 17. North America Personalized Cancer Treatment Market Share by Type (2020-2031)

Figure 18. North America Personalized Cancer Treatment Market Share by Application (2020-2031)

Figure 19. North America Personalized Cancer Treatment Market Share by Country (2020-2031)

Figure 20. United States Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Personalized Cancer Treatment Market Share by Type (2020-2031)

Figure 24. Europe Personalized Cancer Treatment Market Share by Application (2020-2031)

Figure 25. Europe Personalized Cancer Treatment Market Share by Country (2020-2031)

Figure 26. Germany Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. China Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. China Personalized Cancer Treatment Market Share by Type (2020-2031)

Figure 34. China Personalized Cancer Treatment Market Share by Application (2020-2031)

Figure 35. Asia Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia Personalized Cancer Treatment Market Share by Type (2020-2031)

Figure 37. Asia Personalized Cancer Treatment Market Share by Application (2020-2031)

Figure 38. Asia Personalized Cancer Treatment Market Share by Region (2020-2031)

Figure 39. Japan Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. South Korea Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. China Taiwan Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Southeast Asia Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. India Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Australia Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East, Africa, and Latin America Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Personalized Cancer Treatment Market Share by Type (2020-2031)

Figure 47. Middle East, Africa, and Latin America Personalized Cancer Treatment Market Share by Application (2020-2031)

Figure 48. Middle East, Africa, and Latin America Personalized Cancer Treatment Market Share by Country (2020-2031)

Figure 49. Brazil Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Mexico Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Turkey Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Israel Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. GCC Countries Personalized Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Cellworks Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)

Figure 56. Novartis Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)

Figure 57. Gradalis, Inc Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)

Figure 58. TherapySelect Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)

Figure 59. Personalis Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)

Figure 60. RGCC International Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)

Figure 61. Genentech Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)

Figure 62. BMS Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)

Figure 63. OHC - Oncology Hematology Care Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)

Figure 64. CTOAM Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)

Figure 65. Aadi Bioscience Revenue Growth Rate in Personalized Cancer Treatment Business (2020-2025)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed